Literature DB >> 30238135

Resveratrol: an effective pharmacological agent to prevent inflammation-induced atrial fibrillation?

Henry Sutanto1, Dobromir Dobrev2, Jordi Heijman3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30238135     DOI： 10.1007/s00210-018-1566-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  37 in total

1.  Atrial remodeling and the substrate for atrial fibrillation in rat hearts with elevated afterload.

Authors:  Shang-Jin Kim; Stéphanie C M Choisy; Palash Barman; Haifei Zhang; Jules C Hancox; Sandra A Jones; Andrew F James
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-08-23

2.  Targeting atrial fibrillation promoting atrial structural remodeling: is this a viable strategy in patients with heart failure?

Authors:  Na Li; Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-11       Impact factor: 3.000

3.  Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: Characteristics and prognostic implications.

Authors:  Konstantinos C Siontis; Bernard J Gersh; Jill M Killian; Peter A Noseworthy; Pamela McCabe; Susan A Weston; Veronique L Roger; Alanna M Chamberlain
Journal:  Heart Rhythm       Date:  2016-03-04       Impact factor: 6.343

Review 4.  Resveratrol and derivatives for the treatment of atrial fibrillation.

Authors:  István Baczkó; Peter E Light
Journal:  Ann N Y Acad Sci       Date:  2015-07-23       Impact factor: 5.691

5.  The risk of atrial fibrillation in patients with rheumatoid arthritis.

Authors:  Seoyoung C Kim; Jun Liu; Daniel H Solomon
Journal:  Ann Rheum Dis       Date:  2013-04-20       Impact factor: 19.103

6.  Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.

Authors:  Istvan Baczko; David Liknes; Wei Yang; Kevin C Hamming; Gavin Searle; Kristian Jaeger; Zoltan Husti; Viktor Juhasz; Gergely Klausz; Robert Pap; Laszlo Saghy; Andras Varro; Vernon Dolinsky; Shaohua Wang; Vivek Rauniyar; Dennis Hall; Jason Rb Dyck; Peter E Light
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

7.  Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors:  Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

8.  Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study.

Authors:  Jesper Lindhardsen; Ole Ahlehoff; Gunnar Hilmar Gislason; Ole Rintek Madsen; Jonas Bjerring Olesen; Jesper Hastrup Svendsen; Christian Torp-Pedersen; Peter Riis Hansen
Journal:  BMJ       Date:  2012-03-08

9.  Resveratrol ameliorates cardiac dysfunction induced by pressure overload in rats via structural protection and modulation of Ca(2+) cycling proteins.

Authors:  Qi Dong; Zhiye Wu; Xiaoyun Li; Jianyun Yan; Luning Zhao; Chuntao Yang; Junjiang Lu; Ju Deng; Minsheng Chen
Journal:  J Transl Med       Date:  2014-11-26       Impact factor: 5.531

10.  Resveratrol enhances the inotropic effect but inhibits the proarrhythmic effect of sympathomimetic agents in rat myocardium.

Authors:  Jesús Hernandez-Cascales
Journal:  PeerJ       Date:  2017-03-30       Impact factor: 2.984
View more
  3 in total

Review 1.  Alcohol, Drinking Pattern, and Chronic Disease.

Authors:  María Barbería-Latasa; Alfredo Gea; Miguel A Martínez-González
Journal:  Nutrients       Date:  2022-05-07       Impact factor: 6.706

2.  Resveratrol-Encapsulated Mitochondria-Targeting Liposome Enhances Mitochondrial Respiratory Capacity in Myocardial Cells.

Authors:  Takao Tsujioka; Daisuke Sasaki; Atsuhito Takeda; Hideyoshi Harashima; Yuma Yamada
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

Review 3.  Research Progress on Natural Products' Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels.

Authors:  Jinshan He; Sicong Li; Yumeng Ding; Yujia Tong; Xuebin Li
Journal:  Cardiovasc Ther       Date:  2022-03-22       Impact factor: 3.023
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.